CAS NO: | 1372645-37-8 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
生物活性 | Otlertuzumab (TRU-016) is a humanized anti-CD37monoclonal antibody that can be used forcancerresearch[1]. |
IC50& Target | CD37[1] |
体外研究 (In Vitro) | Otlertuzumab (TRU-016) in combination withRituximab(HY-P9913),Rapamycin(HY-10219), orBendamustine(HY-13567) increases cell killing of NHL cells[2]. |
体内研究 (In Vivo) | Otlertuzumab (TRU-016) in combination withBendamustine(HY-13567) displays greater anti-tumor activity than either agent alone against a follicular lymphoma tumor model in SCID mice[2]. |
Clinical Trial | |
CAS 号 | 1372645-37-8 |
中文名称 | 奥乐妥珠单抗 |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |